RIFAXIKEM 200 ,Rifaximin (200mg): USES, SIDE EFFECT, INTERACTIONS, PICTURES, AND ETC

Apr 12, 2024

  • RIFAXIKEM 200 & Rifaximin (200mg

 RIFAXIKEM is a line of medications featuring Rifaximin in various strengths—200mg, 400mg, and 550mg—catering to different needs and conditions related to gastrointestinal health. Rifaximin, the active ingredient, is a non-absorbable antibiotic that targets intestinal pathogens without affecting the overall balance of gut flora.

  • Uses of RIFAXIKEM

RIFAXIKEM is primarily prescribed for the treatment of irritable bowel syndrome with diarrhea (IBS-D) and for preventing and treating travelers’ diarrhea. Additionally, the 550mg dosage is often used in the management of hepatic encephalopathy to reduce the risk of recurrent episodes. This medication works by reducing the growth of bacteria that cause diarrhea and by altering the bacterial content in the intestines, which can improve symptoms of IBS-D and hepatic encephalopathy.

  • Benefits of RIFAXIKEM

The RIFAXIKEM series offers targeted action against diarrhea-causing bacteria while minimizing impact on beneficial gut bacteria, making it a favorable option for long-term management of gastrointestinal conditions. Its efficacy in reducing symptoms of bloating, abdominal pain, and frequent bowel movements provides significant relief for sufferers of IBS-D and travelers' diarrhea.

  • Potential Side Effects

RIFAXIKEM is well-tolerated by most patients, but some may experience mild side effects such as nausea, dizziness, or an altered sense of taste. Less commonly, allergic reactions, such as rash or itching, may occur. It’s important to consult a healthcare provider if any adverse effects are noticed.

  • Drug Interactions

Being a targeted antibiotic, Rifaximin has fewer interactions with other drugs compared to systemic antibiotics. However, it's crucial to inform your healthcare provider about all medications you're currently taking to avoid any potential interactions, especially if you are on anticoagulants or anti-inflammatory drugs.

  • Visual Guide and More

Images of RIFAXIKEM packaging and the tablets themselves can aid in ensuring that patients receive and use the correct medication. Visual identification is an essential aspect of patient education and safety.

  • Conclusion

The RIFAXIKEM series offers a versatile and effective approach to managing specific gastrointestinal conditions with its range of dosages tailored to the severity and type of condition being treated. Whether for IBS-D, travelers' diarrhea, or hepatic encephalopathy, RIFAXIKEM provides a strategic solution to improve quality of life.

For more detailed information on dosing and whether RIFAXIKEM is right for you, consult your healthcare provider or visit the product's official website

A team of highly skilled professionals in the pharmaceutical field established Steris Healthcare Pvt Ltd in February 2018. Sterispharma is a certified pharmaceutical company by WHO, GMP, and ISO, situated in Navi Mumbai. It is dedicated to delivering high-quality medications at competitive prices to customers across India, adhering to WHO's stringent standards. Through Steris's online pharmacy, customers can conveniently purchase medicines and receive home delivery. Our primary objective at Steris is to offer a comprehensive range of healthcare products to fulfill the diverse requirements of the healthcare industry. Steris is committed to meeting the healthcare sector's demands, whether it's specialized treatments, medications for rare diseases, or essential pharmacA euticals. The range of Steris healthcare products caters to various medical needs, including Cardiology, Asthma, Respiratory, Nasal, Diabetes, Endocrinology, Gastrology, Orthopedics, Anti-infective/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental, and Dermatology.  For further information:  EMAIL:  info@sterispharma.com  / contact@sterispharma.com     CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668   

  BUY NOW

 

SHARE WITH